Zhenhua Liu

27PUBLICATIONS
89CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infectious diseasesChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 18, 2026
MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

|Nov 13, 2025
Anti-epidermal growth factor receptor monoclonal antibody combined with chemotherapy in penile cancer: A prospective, multicenter, phase 1 study.

Pei Shu, Shuang Zhang, Dingwei Ye

|Jul 29, 2025
Circulating Plasma Proteins as Biomarkers for Immunotherapy Toxicity: Insights from Proteome-Wide Mendelian Randomization and Bioinformatics Analysis.

Liansha Tang, Wenbo He, Handan Hu

|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.

Xingming Zhang, Junjie Zhao, Xiaoxue Yin

|Apr 26, 2025
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2.

Le Li, Tang Feng, Quan Shen

|Nov 28, 2024
Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial.

Yu-Chun Zhu, Zhi-Gong Wei, Jing-Jing Wang

Pageof 5

Frequent Collaborators

10 joint publications

Yali Shen

8 joint publications

Rui Huang

5 joint publications

Xinan Sheng

3 joint publications

Zhenhua Liu